GeneralBullishBlockonomi · 11h ago6/10
📰
AlzeCure Pharma (ALZCUR) Stock Jumps Over 300% on Eli Lilly Partnership
AlzeCure Pharma's stock surged 301% following a licensing deal with pharmaceutical giant Eli Lilly valued at over $1 billion for the Alzheimer's drug candidate ACD680. This partnership represents significant validation of AlzeCure's therapeutic approach and demonstrates major pharma's confidence in the company's pipeline.